Wed, March 21, 2012
Tue, March 20, 2012
[ Tue, Mar 20th 2012 ]: Market Wire
Malbex Q1 Update
[ Tue, Mar 20th 2012 ]: Market Wire
Glencore to Acquire Viterra
Mon, March 19, 2012
[ Mon, Mar 19th 2012 ]: Market Wire
Balmoral Exploration Update
Sat, March 17, 2012
Fri, March 16, 2012
[ Fri, Mar 16th 2012 ]: Market Wire
News Release
Thu, March 15, 2012
[ Thu, Mar 15th 2012 ]: Market Wire
Viterra Issues Statement
Wed, March 14, 2012

Matthew Harrison Downgraded (VRTX) to Sell and Held Target at $30 on, Mar 19th, 2012


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. sell-and-held-target-at-30-on-mar-19th-2012.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Matthew Harrison of Morgan Stanley, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Sell and Held Target at $30 on, Mar 19th, 2012.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $49 on, Wednesday, March 14th, 2012

Publication Contributing Sources